Compass Therapeutics, Inc. (CMPX) Earnings
Compass Therapeutics, Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Next earnings (estimated)
Around Nov 12, 2026
From past filing pattern
Get notified when CMPX reports →Last reported earnings
Aug 6, 2026
From the latest earnings 8-K
Revenue • FY2025
$0
▼ 100.0%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from CMPX's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $0 | -$66.49M | — | — | -$49.17M | — | -100.0% |
| FY2024 | $850K | -$49.38M | — | — | -$44.9M | -6661.8% | — |
| FY2023 | $0 | -$42.49M | — | — | -$40.65M | — | — |
| FY2022 | $0 | -$39.23M | — | — | -$34.34M | — | — |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Aug 6, 2026 | 8-K (2.02) | 0001171843-26-005292EDGAR |
| May 5, 2026 | 8-K (2.02) | 0001171843-26-003005EDGAR |
| Mar 5, 2026 | 8-K (2.02) | 0001171843-26-001336EDGAR |
| Jan 6, 2026 | 8-K (2.02) | 0001171843-26-000083EDGAR |
| Nov 5, 2025 | 8-K (2.02) | 0001171843-25-007004EDGAR |
| Aug 11, 2025 | 8-K (2.02) | 0001171843-25-005260EDGAR |
| May 8, 2025 | 8-K (2.02) | 0001171843-25-002952EDGAR |
| Feb 27, 2025 | 8-K (2.02) | 0001171843-25-001105EDGAR |
Never miss a CMPX filing.
Get an email when CMPX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 8, 2026Source: SEC EDGAR.